Your browser doesn't support javascript.
loading
A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa.
Al-Emran, Hassan M; Eibach, Daniel; Krumkamp, Ralf; Ali, Mohammad; Baker, Stephen; Biggs, Holly M; Bjerregaard-Andersen, Morten; Breiman, Robert F; Clemens, John D; Crump, John A; Cruz Espinoza, Ligia Maria; Deerin, Jessica; Dekker, Denise Myriam; Gassama Sow, Amy; Hertz, Julian T; Im, Justin; Ibrango, Samuel; von Kalckreuth, Vera; Kabore, Leon Parfait; Konings, Frank; Løfberg, Sandra Valborg; Meyer, Christian G; Mintz, Eric D; Montgomery, Joel M; Olack, Beatrice; Pak, Gi Deok; Panzner, Ursula; Park, Se Eun; Razafindrabe, Jean Luco Tsiriniaina; Rabezanahary, Henintsoa; Rakotondrainiarivelo, Jean Philibert; Rakotozandrindrainy, Raphaël; Raminosoa, Tiana Mirana; Schütt-Gerowitt, Heidi; Sampo, Emmanuel; Soura, Abdramane Bassiahi; Tall, Adama; Warren, Michelle; Wierzba, Thomas F; May, Jürgen; Marks, Florian.
  • Al-Emran HM; Bernhard Nocht Institute for Tropical Medicine German Center for Infection Research, partner site Hamburg-Borstel-Lübeck, Hamburg, Germany.
  • Eibach D; Bernhard Nocht Institute for Tropical Medicine German Center for Infection Research, partner site Hamburg-Borstel-Lübeck, Hamburg, Germany.
  • Krumkamp R; Bernhard Nocht Institute for Tropical Medicine German Center for Infection Research, partner site Hamburg-Borstel-Lübeck, Hamburg, Germany.
  • Ali M; International Vaccine Institute, Seoul, Republic of Korea Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Baker S; Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Biggs HM; Division of Infectious Diseases and International Health, Duke University Medical Center Duke Global Health Institute, Duke University, Durham, North Carolina.
  • Bjerregaard-Andersen M; Bandim Health Project, Bissau, Guinea-Bissau Research Center for Vitamins and Vaccines, Copenhagen, Denmark.
  • Breiman RF; Kenya Medical Research Institute-Centers for Disease Control and Prevention Kenya Collaboration, Nairobi Global Health Institute, Emory University, Atlanta, Georgia.
  • Clemens JD; International Vaccine Institute, Seoul, Republic of Korea International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka.
  • Crump JA; Division of Infectious Diseases and International Health, Duke University Medical Center Duke Global Health Institute, Duke University, Durham, North Carolina Kilimanjaro Christian Medical Centre, Moshi, Tanzania Centre for International Health, University of Otago, Dunedin, New Zealand.
  • Cruz Espinoza LM; International Vaccine Institute, Seoul, Republic of Korea.
  • Deerin J; International Vaccine Institute, Seoul, Republic of Korea.
  • Dekker DM; Bernhard Nocht Institute for Tropical Medicine German Center for Infection Research, partner site Hamburg-Borstel-Lübeck, Hamburg, Germany.
  • Gassama Sow A; Institut Pasteur de Dakar, Université Cheikh Anta Diop de Dakar, Senegal.
  • Hertz JT; Division of Infectious Diseases and International Health, Duke University Medical Center Duke Global Health Institute, Duke University, Durham, North Carolina.
  • Im J; International Vaccine Institute, Seoul, Republic of Korea.
  • Ibrango S; Ministry of Health.
  • von Kalckreuth V; International Vaccine Institute, Seoul, Republic of Korea.
  • Kabore LP; Schiphra Hospital, Ouagadougou, Burkina Faso.
  • Konings F; International Vaccine Institute, Seoul, Republic of Korea.
  • Løfberg SV; Bandim Health Project, Bissau, Guinea-Bissau Research Center for Vitamins and Vaccines, Copenhagen, Denmark.
  • Meyer CG; Bernhard Nocht Institute for Tropical Medicine Institute of Tropical Medicine, Eberhard-Karls University Tübingen, Germany.
  • Mintz ED; National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Montgomery JM; Kenya Medical Research Institute-Centers for Disease Control and Prevention Kenya Collaboration, Nairobi.
  • Olack B; Kenya Medical Research Institute-Centers for Disease Control and Prevention Kenya Collaboration, Nairobi.
  • Pak GD; International Vaccine Institute, Seoul, Republic of Korea.
  • Panzner U; International Vaccine Institute, Seoul, Republic of Korea.
  • Park SE; International Vaccine Institute, Seoul, Republic of Korea.
  • Razafindrabe JL; University of Antananarivo, Madagascar.
  • Rabezanahary H; University of Antananarivo, Madagascar.
  • Rakotondrainiarivelo JP; University of Antananarivo, Madagascar.
  • Rakotozandrindrainy R; University of Antananarivo, Madagascar.
  • Raminosoa TM; University of Antananarivo, Madagascar.
  • Schütt-Gerowitt H; International Vaccine Institute, Seoul, Republic of Korea Institute of Medical Microbiology, University of Cologne, Germany.
  • Sampo E; Institute of Medical Microbiology, University of Cologne, Germany.
  • Soura AB; University of Ouagadougou, Burkina Faso.
  • Tall A; Institut Pasteur de Dakar, Université Cheikh Anta Diop de Dakar, Senegal.
  • Warren M; International Vaccine Institute, Seoul, Republic of Korea.
  • Wierzba TF; International Vaccine Institute, Seoul, Republic of Korea.
  • May J; Bernhard Nocht Institute for Tropical Medicine German Center for Infection Research, partner site Hamburg-Borstel-Lübeck, Hamburg, Germany.
  • Marks F; International Vaccine Institute, Seoul, Republic of Korea.
Clin Infect Dis ; 62 Suppl 1: S42-6, 2016 Mar 15.
Article en En | MEDLINE | ID: mdl-26933020

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Salmonella typhi / Fiebre Tifoidea / Ciprofloxacina / Farmacorresistencia Bacteriana / Antibacterianos Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País como asunto: Africa Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Salmonella typhi / Fiebre Tifoidea / Ciprofloxacina / Farmacorresistencia Bacteriana / Antibacterianos Tipo de estudio: Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País como asunto: Africa Idioma: En Año: 2016 Tipo del documento: Article